Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.14 USD | +0.78% | +1.74% | -41.79% |
Apr. 17 | Thoughtworks Holding Unveils Acquisition to Expand AI Expertise | MT |
Mar. 19 | Citigroup Cuts Healthcare Realty Trust Price Target to $13 From $17.50, Maintains Neutral Rating | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company appears to be poorly valued given its net asset value.
- The company is one of the best yield companies with high dividend expectations.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company has insufficient levels of profitability.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- Based on current prices, the company has particularly high valuation levels.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-41.79% | 5.35B | - | ||
+4.62% | 55.56B | A- | ||
-11.72% | 17.46B | A- | ||
-5.05% | 13.01B | A | ||
+1.40% | 7.63B | B | ||
+8.62% | 3.23B | C- | ||
-2.31% | 3.16B | C+ | ||
-5.42% | 3.02B | B+ | ||
-8.15% | 2.76B | C | ||
+12.61% | 2.72B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HR Stock
- HR Stock
- Ratings Healthcare Realty Trust